Literature DB >> 17201655

Filoviruses and the balance of innate, adaptive, and inflammatory responses.

Mansour Mohamadzadeh1, Lieping Chen, Gene G Olinger, William D Pratt, Alan L Schmaljohn.   

Abstract

The Filoviruses Marburg virus and Ebola virus are among the deadliest of human pathogens, causing fulminant hemorrhagic fevers typified by overmatched specific immune responses and profuse inflammatory responses. Keys to both vaccination and treatment may reside, first, in the understanding of immune dysfunctions that parallel Filoviral disease and, second, in devising ways to redirect and restore normal immune function as well as to mitigate inflammation. Here, we describe how Filoviral infections may subvert innate immune responses through perturbances of dendritic cells and neutrophils, with particular emphasis on the downstream effects on adaptive immunity and inflammation. We suggest that pivotal events may be subject to therapeutic intervention as Filoviruses encounter immune processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17201655     DOI: 10.1089/vim.2006.19.602

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  7 in total

Review 1.  Progress in filovirus vaccine development: evaluating the potential for clinical use.

Authors:  Darryl Falzarano; Thomas W Geisbert; Heinz Feldmann
Journal:  Expert Rev Vaccines       Date:  2011-01       Impact factor: 5.217

2.  Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.

Authors:  Kang Yiu Lai; Wing Yiu George Ng; Fan Fanny Cheng
Journal:  Infect Dis Poverty       Date:  2014-11-28       Impact factor: 4.520

Review 3.  Applications of high-throughput genomics to antiviral research: evasion of antiviral responses and activation of inflammation during fulminant RNA virus infection.

Authors:  John C Kash
Journal:  Antiviral Res       Date:  2009-04-16       Impact factor: 5.970

4.  P58(IPK): a novel "CIHD" member of the host innate defense response against pathogenic virus infection.

Authors:  Alan G Goodman; Jamie L Fornek; Guruprasad R Medigeshi; Lucy A Perrone; Xinxia Peng; Matthew D Dyer; Sean C Proll; Sue E Knoblaugh; Victoria S Carter; Marcus J Korth; Jay A Nelson; Terrence M Tumpey; Michael G Katze
Journal:  PLoS Pathog       Date:  2009-05-22       Impact factor: 6.823

5.  Correspondence of Neutralizing Humoral Immunity and CD4 T Cell Responses in Long Recovered Sudan Virus Survivors.

Authors:  Ariel Sobarzo; Spencer W Stonier; Andrew S Herbert; David E Ochayon; Ana I Kuehne; Yael Eskira; Shlomit Fedida-Metula; Neta Tali; Eli C Lewis; Moses Egesa; Stephen Cose; Julius Julian Lutwama; Victoria Yavelsky; John M Dye; Leslie Lobel
Journal:  Viruses       Date:  2016-05-11       Impact factor: 5.048

Review 6.  The lifecycle of the Ebola virus in host cells.

Authors:  Dong-Shan Yu; Tian-Hao Weng; Xiao-Xin Wu; Frederick X C Wang; Xiang-Yun Lu; Hai-Bo Wu; Nan-Ping Wu; Lan-Juan Li; Hang-Ping Yao
Journal:  Oncotarget       Date:  2017-06-15

7.  Sudan ebolavirus long recovered survivors produce GP-specific Abs that are of the IgG1 subclass and preferentially bind FcγRI.

Authors:  Olga Radinsky; Avishay Edri; Michael Brusilovsky; Shlomit Fedida-Metula; Ariel Sobarzo; Orly Gershoni-Yahalom; Julius Lutwama; John Dye; Leslie Lobel; Angel Porgador
Journal:  Sci Rep       Date:  2017-07-20       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.